We are live on ! Find out more
SAM

Silvercrest Asset Management Portfolio holdings

AUM $13.8B
1-Year Est. Return 28.39%
This Fund
S&P 500
This Quarter Est. Return
-2.69%
1 Year Est. Return
+28.39%
3 Year Est. Return
+72%
5 Year Est. Return
+95.52%
10 Year Est. Return
+377.43%
AUM
$15.4B
AUM Growth
-$389M
Cap. Flow
+$442M
Cap. Flow %
2.87%
Top 10 Hldgs %
11.79%
Holding
902
New
69
Increased
396
Reduced
272
Closed
51

Sector Composition

Rank Sector Weight
1 Technology 16.41%
2 Financials 15.63%
3 Industrials 15.04%
4 Healthcare 13.15%
5 Consumer Discretionary 9.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
151
Merck
MRK
$322B
$28.8M 0.19%
350,644
-4,032
-1% -$318K
GTLS
152
DELISTED
Chart Industries
GTLS
$28.1M 0.18%
163,512
+21,747
+15% +$3.05M
V icon
153
Visa
V
$677B
$28M 0.18%
126,339
+1,843
+1% +$399K
EVH icon
154
Evolent Health
EVH
$371M
$28M 0.18%
867,085
-4,656
-0.5% -$122K
EA icon
155
Electronic Arts
EA
$52.7B
$27.4M 0.18%
216,326
+13,698
+7% +$1.78M
AQUA
156
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$27M 0.18%
575,321
-7,263
-1% -$310K
IWO icon
157
iShares Russell 2000 Growth ETF
IWO
$14.1B
$26.9M 0.18%
105,360
-1,168
-1% -$299K
EAT icon
158
Brinker International
EAT
$8.82B
$26.9M 0.18%
705,911
-12,208
-2% -$457K
CHEF icon
159
Chefs' Warehouse
CHEF
$4.31B
$26.7M 0.17%
818,254
+124,401
+18% +$3.91M
TMO icon
160
Thermo Fisher Scientific
TMO
$214B
$26.6M 0.17%
45,007
+662
+1% +$380K
EVOP
161
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$26.4M 0.17%
1,143,622
-8,199
-0.7% -$195K
DD icon
162
DuPont de Nemours
DD
$18.6B
$26.1M 0.17%
282,713
+274,632
+3,398% +$26.8M
SNX icon
163
TD Synnex
SNX
$19.9B
$25.8M 0.17%
249,787
+117,154
+88% +$12.5M
COP icon
164
ConocoPhillips
COP
$144B
$25.5M 0.17%
254,741
+154,608
+154% +$14.2M
JPM icon
165
JPMorgan Chase
JPM
$916B
$25.1M 0.16%
184,205
-11,939
-6% -$1.76M
NVRI icon
166
Enviri
NVRI
$624M
$24.8M 0.16%
2,028,358
-999,842
-33% -$14.7M
RRX icon
167
Regal Rexnord
RRX
$12.5B
$24.7M 0.16%
165,792
-1,845
-1% -$296K
FLWS icon
168
1-800-Flowers.com
FLWS
$252M
$24.7M 0.16%
1,932,488
+99,347
+5% +$1.71M
DAL icon
169
Delta Air Lines
DAL
$56.7B
$23.7M 0.15%
598,042
+62,568
+12% +$2.44M
WLY icon
170
John Wiley & Sons Class A
WLY
$2.83B
$23.3M 0.15%
439,439
+487
+0.1% +$25.6K
PLOW icon
171
Douglas Dynamics
PLOW
$992M
$23.1M 0.15%
667,505
+3,449
+0.5% +$125K
PGNY icon
172
Progyny
PGNY
$2.46B
$23M 0.15%
448,277
+47,121
+12% +$2.02M
PCRX icon
173
Pacira BioSciences
PCRX
$1.04B
$22.8M 0.15%
298,236
-56,370
-16% -$3.76M
HES
174
DELISTED
Hess
HES
$22.3M 0.14%
208,149
+129,700
+165% +$12.3M
AZTA icon
175
Azenta
AZTA
$1.3B
$21.4M 0.14%
258,108
+110,017
+74% +$9.44M

Similar funds

Silvercrest Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Silvercrest Asset Management held 902 positions worth $15.4B, down 2.5% from $15.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Silvercrest Asset Management's Q1 2022 filing shows 69 new, 396 increased, 272 reduced and 51 closed positions. Its largest new stake was Franchise Group, Inc.: 863,742 shares worth $35.8M. The largest sale was First Horizon, an estimated $57.6M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.

  • Silvercrest Asset Management's largest Q1 2022 buy was Franchise Group, Inc.: 863,742 shares worth $35.8M.
  • Silvercrest Asset Management added most to Concentrix in Q1 2022, an estimated $143M increase.
  • Silvercrest Asset Management's biggest Q1 2022 reduction was First Horizon, cutting an estimated $57.6M.
  • Silvercrest Asset Management fully exited Envista in Q1 2022, selling an estimated $44.3M.
  • Silvercrest Asset Management's ten largest holdings make up 12% of its $15.4B portfolio in Q1 2022.
  • Silvercrest Asset Management opened 69 new positions and closed 51 in Q1 2022.
  • Silvercrest Asset Management's portfolio value fell 2.5% quarter-over-quarter to $15.4B.

Based on Silvercrest Asset Management's 13F filing for Q1 2022, filed 16 May 2022.